Minnesota Cancer Action Center

SAINT PAUL, Minn. – Today, Governor Tim Walz signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Minnesotans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer

ST. PAUL, Minn . – “As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Minnesotans. “ACS CAN calls on the legislature to improve coverage of comprehensive biomarker testing,

The House Preventive Health Policy Division voted in favor of advancing House File 3153, which would ensure that Medicare Assistance and MinnesotaCare enrollees have insurance coverage for individual, group and telephone counseling, as well as all FDA-approved tobacco cessation medications without cost-sharing or other barriers.

During this legislative session, the American Cancer Society Cancer Action Network (ACS CAN) prompts legislators to prioritize passing public policies that promote cancer prevention, improve patient quality of life, prevent youth commercial tobacco use and help adults quit tobacco, and expand equitable access to quality, affordable health care.